Armata Pharmaceuticals | 8-K: Armata Pharmaceuticals Announces First Quarter 2024 Results and Provides Corporate Update
Armata Pharmaceuticals | DEF 14A: Definitive information statements
Armata Pharmaceuticals | 8-K: Current report
Armata Pharmaceuticals | 8-K: Armata Pharmaceuticals Announces Fourth Quarter and Full-Year 2023 Results and Provides Corporate Update
Armata Pharmaceuticals | 8-K: Current report
Armata Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Armata Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Armata Pharmaceuticals | 8-K: Armata Pharmaceuticals Announces Third Quarter 2023 Results and Provides Corporate Update
Armata Pharmaceuticals | 8-K: Current report
Armata Pharmaceuticals | 8-K: Armata Pharmaceuticals Announces Second Quarter 2023 Results and Provides Corporate Update
Armata Pharmaceuticals | DEFA14A: Others
Armata Pharmaceuticals | DEF 14A: Definitive information statements
Armata Pharmaceuticals | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Armata Pharmaceuticals | 8-K: Current report
Armata Pharmaceuticals | 8-K: Current report
Armata Pharmaceuticals | 8-K: Current report
Armata Pharmaceuticals | 8-K: Armata Pharmaceuticals Announces First Quarter 2023 Results and Provides Corporate Update
Armata Pharmaceuticals | 8-K: Current report
Armata Pharmaceuticals | S-3/A: Registration statement for specified transactions by certain issuers (Amendment)
Armata Pharmaceuticals | 8-K: Armata Pharmaceuticals Announces Fourth Quarter and Full-Year 2022 Results and Provides Corporate Update
No Data